The role of mitochondria in the development and progression of lung cancer

Computational and Structural Biotechnology Journal

Volumn 6, Issue 7, 2013, Pages e201303019-

  Roberts, Emily R ^a   Thomas, Kelly Jean ^a  

^a and Mass Communication   (United States)

Author keywords

Apoptosis; Mitochondrial dynamics; Mitochondrial dysfunction; Non small cell lung cancer; Tumorigenesis

Indexed keywords

EID: 84902176690     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.5936/csbj.201303019     Document Type: Conference Paper

References (147)

1. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495-516. (Pubitemid 46911891)
2. (2013) Cancer Fact Sheet N.297. In: Organization WH, editor.
3. (2012) Cancer Facts and Figures.: American Cancer Society.
4. (2010) SEER Cancer Statistics Review, 1975-2010. In: Institute NC, editor: U. S. National Institutes of Health.
5. (2011) A Snapshot of Lung Cancer. In: Institute NC, editor: U. S. National Institutes of Health.
6. Solaini G, Sgarbi G, Baracca A (2011) Oxidative phosphorylation in cancer cells. Biochim Biophys Acta 1807:534-542.
7. Dasgupta S, Soudry E, Mukhopadhyay N, Shao C, Yee J, et al. (2012) Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation. J Cell Physiol 227:2451-2460.
8. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270.
9. Plas DR, Thompson CB (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24:7435-7442. (Pubitemid 41637983)
10. Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, et al. (2004) Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev 18:2095-2107. (Pubitemid 39166627)
11. Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouyssegur J, et al. (2010) Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol 222:648-657.
12. de Moura MB, dos Santos LS, Van Houten B (2010) Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen 51:391-405.
13. Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, et al. (2004) Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. Faseb J 18:1303-1305. (Pubitemid 39561584)
14. El Mjiyad N, Caro-Maldonado A, Ramirez-Peinado S, Munoz-Pinedo C (2011) Sugar-free approaches to cancer cell killing. Oncogene 30:253-264.
15. Ramanathan A, Wang C, Schreiber SL (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 102:5992-5997. (Pubitemid 40594243)
16. Yeung SJ, Pan J, Lee MH (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65:3981-3999.
17. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, et al. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18:283-293. (Pubitemid 41350534)
18. Li J, Jiang P, Robinson M, Lawrence TS, Sun Y (2003) AMPK-betal subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis 24:827-834. (Pubitemid 36748898)
19. Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9:563-575.
20. Hallstrom TC, Mori S, Nevins JR (2008) An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13:11-22. (Pubitemid 350309738)
21. Prochownik EV (2008) c-Myc: linking transformation and genomic instability. Curr Mol Med 8:446-458.
22. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11. (Pubitemid 29018404)
23. Morrish F, Neretti N, Sedivy JM, Hockenbery DM (2008) The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 7:1054-1066.
24. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120. (Pubitemid 44040989)
25. Corcoran CA, Huang Y, Sheikh MS (2006) The regulation of energy generating metabolic pathways by p53. Cancer Biol Ther 5:1610-1613.
26. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T (1996) Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 93:11848-11852. (Pubitemid 26347212)
27. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, et al. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458-470.
28. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53 regulates mitochondrial respiration. Science 312:1650-1653. (Pubitemid 43902663)
29. Sinthupibulyakit C, Ittarat W, St Clair WH, St Clair DK (2010) p53 Protects lung cancer cells against metabolic stress. Int J Oncol 37:1575-1581.
30. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85-95.
31. Xu CX, Jin H, Shin JY, Kim JE, Cho MH (2010) Roles of protein kinase B/Akt in lung cancer. Front Biosci (Elite Ed) 2:1472-1484.
32. Miyazono F, Schneider PM, Metzger R, Warnecke-Eberz U, Baldus SE, et al. (2002) Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene 21:3780-3783. (Pubitemid 34620540)
33. Servais S, Couturier K, Koubi H, Rouanet JL, Desplanches D, et al. (2003) Effect of voluntary exercise on H202 release by subsarcolemmal and intermyofibrillar mitochondria. Free Radic Biol Med 35:24-32. (Pubitemid 36782334)
34. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, et al. (2008) Alteration of APEl/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer 60:277-284. (Pubitemid 351622081)
35. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, et al. (2007) Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 67:8043-8050. (Pubitemid 47395138)
36. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, et al. (1997) Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 18:682-685. (Pubitemid 27226964)
37. Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D (1995) Somatic mitochondrial mutation in gastric cancer. Am J Pathol 147:1105-1111.
38. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, et al. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019. (Pubitemid 30158678)
39. Habano W, Sugai T, Nakamura SI, Uesugi N, Yoshida T, et al. (2000) Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 118:835-841. (Pubitemid 30243746)
40. Habano W, Sugai T, Yoshida T, Nakamura S (1999) Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83:625-629. (Pubitemid 29508041)
41. Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, et al. (1999) Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer 35:316-319. (Pubitemid 29136785)
42. Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, et al. (2003) Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 9:5636-5641. (Pubitemid 37499485)
43. Yang Ai SS, Hsu K, Herbert C, Cheng Z, Hunt J, et al. (2013) Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Respir Med 107:911-918.
44. Bonner MR, Shen M, Liu CS, Divita M, He X, et al. (2009) Mitochondrial DNA content and lung cancer risk in Xuan Wei, China. Lung Cancer 63:331-334.
45. Hosgood HD, 3rd, Liu CS, Rothman N, Weinstein SJ, Bonner MR, et al. (2010) Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study. Carcinogenesis 31:847-849.
46. Chatterjee A, Dasgupta S, Sidransky D (2011) Mitochondrial subversion in cancer. Cancer Prev Res (Phila) 4:638-654.
47. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664. (Pubitemid 351928347)
48. Thomas KJ, Sandebring A, Beilina A, van der Brug M, Cleland MM, et al. (2009) Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS One 4:e5701.
49. Tsujimoto Y, Shimizu S (2000) VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 7:1174-1181. (Pubitemid 32042224)
50. Bowen IaSB (1990) Programmed cell death in tumors and tissues.. London, UK: Chapman and Hall.
51. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, et al. (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655-1663. (Pubitemid 40478589)
52. Joseph B, Ekedahl J, Sirzen F, Lewensohn R, Zhivotovsky B (1999) Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 262:381-387. (Pubitemid 29429877)
53. Joseph B, Ekedahl J, Lewensohn R, Marchetti P, Formstecher P, et al. (2001) Defective caspase-3 relocalization in non-small cell lung carcinoma. Oncogene 20:2877-2888. (Pubitemid 33027755)
54. Hersey P, Zhang XD (2001) How melanoma cells evade trailinduced apoptosis. Nat Rev Cancer 1:142-150. (Pubitemid 33741889)
55. Sirzen F, Zhivotovsky B, Nilsson A, Bergh J, Lewensohn R (1998) Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax. Lung Cancer 22:1-13. (Pubitemid 28526438)
56. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6:1796-1803. (Pubitemid 30305074)
57. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320. (Pubitemid 28551107)
58. Monzo M, Rosell R Felip E, Astudillo J, Sanchez JJ, et al. (1999) A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17:2100-2104. (Pubitemid 29318841)
59. Xiang J, Chao DT, Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 93:14559-14563. (Pubitemid 26419006)
60. Lu CD, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812. (Pubitemid 28217451)
61. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, et al. (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805-2809. (Pubitemid 30395796)
62. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71. (Pubitemid 33676964)
63. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899-905.
64. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, et al. (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856-859.
65. Ren D, Tu HC, Kim H, Wang GX, Bean GR, et al. (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330:1390-1393.
66. Joseph B, Lewensohn R, Zhivotovsky B (2000) Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann N Y Acad Sci 926:204-216. (Pubitemid 32050157)
67. Groeger AM, Caputi M, Esposito V, Baldi A, Rossiello R, et al. (2000) Expression of p21 in non small cell lung cancer relationship with PCNA Anticancer Res 20:3301-3305.
68. Maitra A, Amirkhan RH, Saboorian MH, Frawley WH, Ashfaq R (1999) Survival in small cell lung carcinoma is independent of Bcl-2 expression. Hum Pathol 30:712-717. (Pubitemid 29266733)
69. Caputi M, Groeger AM, Esposito V, De Luca A, Murabito M, et al. (1999) Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer. Anticancer Res 19:825-827. (Pubitemid 29168339)
70. Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, et al. (2011) Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 10:188-193.
71. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, et al. (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9:423-432. (Pubitemid 34195566)
72. Sasaki H, Nonaka M, Fujii Y, Yamakawa Y, Fukai I, et al. (2001) Expression of the prothymosin-a gene as a prognostic factor in lung cancer. Surg Today 31:936-938. (Pubitemid 33036173)
73. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR (1998) Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 79:468-475. (Pubitemid 28445267)
74. Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, et al. (2001) p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res 61:88-96. (Pubitemid 32095705)
75. Hasty P, Christy BA (2013) p53 as an intervention target for cancer and aging. Pathobiol Aging Age Relat Dis 3.
76. Viktorsson K, De Petris L, Lewensohn R (2005) The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun 331:868-880. (Pubitemid 40615518)
77. Rodin SN, Rodin AS (2005) Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol 15:103-112. (Pubitemid 40126241)
78. Dowell SP, Wilson PO, Derias NW, Lane DP, Hall PA (1994) Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens. Cancer Res 54:2914-2918. (Pubitemid 24187772)
79. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, et al. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321-328. (Pubitemid 37329796)
80. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A 100:1931-1936. (Pubitemid 36254551)
81. Suzuki K, Matsubara H (2011) Recent advances in p53 research and cancer treatment. J Biomed Biotechnol 2011:978312.
82. Sun SH, Zheng M, Ding K, Wang S, Sun Y (2008) A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Biol Ther 7:845-852.
83. Zhai D, Jin C, Satterthwait AC, Reed JC (2006) Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ 13:1419-1421. (Pubitemid 44057478)
84. Cory S, Adams JM (2005) Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell 8:5-6. (Pubitemid 40991809)
85. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, et al. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435:677-681. (Pubitemid 40825512)
86. Wesarg E, Hoffarth S, Wiewrodt R, Kroll M, Biesterfeld S, et al. (2007) Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer. Int J Cancer 121:2387-2394. (Pubitemid 350022407)
87. Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, et al. (2011) Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J Clin Oncol 29:909-916.
88. Farmer G (2004) Targeted lung cancer therapies. Nat Rev Drug Discov 3:547-548. (Pubitemid 39022978)
89. Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, et al. (2006) Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol 2:543-550. (Pubitemid 44413237)
90. Voortman J, Resende TP, Abou El Hassan MA, Giaccone G, Kruyt FA (2007) TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib. Mol Cancer Ther 6:2103-2112. (Pubitemid 47052501)
91. Hlobilkova A, Knillova J, Svachova M, Skypalova P, Krystof V, et al. (2006) Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells. Anticancer Res 26:1015-1022.
92. Jin H, Xu CX, Kim HW, Chung YS, Shin JY, et al. (2008) Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras (LAl) mice. Cancer Gene Ther 15:275-283. (Pubitemid 351508133)
93. Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241-1252. (Pubitemid 43929096)
94. Liesa M, Shirihai OS (2013) Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 17:491-506.
95. Bonda DJ, Smith MA, Perry G, Lee HG, Wang X, et al. (2011) The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. Curr Pharm Des 17:3374-3380.
96. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ (2006) Role of Bax and Bak in mitochondrial morphogenesis. Nature 443:658-662. (Pubitemid 44564703)
97. Roux A, Uyhazi K, Frost A, De Camilli P (2006) GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature 441:528-531. (Pubitemid 44050156)
98. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, et al. (2003) Mitofusins Mfnl and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160:189-200. (Pubitemid 36254953)
99. Arnoult D, Bartle LM, Skaletskaya A, Poncet D, Zamzami N, et al. (2004) Cytomegalovirus cell death suppressor vMIA blocks Bax-but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc Natl Acad Sci U S A 101:7988-7993. (Pubitemid 38698041)
100. Griparic L, Kanazawa T, van der Bliek AM (2007) Regulation of the mitochondrial dynamin-like protein Opal by proteolytic cleavage. J Cell Biol 178:757-764. (Pubitemid 47347361)
101. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC (2003) Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 160:1115-1127. (Pubitemid 36443879)
102. Estaquier J, Arnoult D (2007) Inhibiting Drpl-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ 14:1086-1094. (Pubitemid 46785100)
103. Fang L, Hemion C, Goldblum D, Meyer P, Orgul S, et al. (2012) Inactivation of MARCH 5 prevents mitochondrial fragmentation and interferes with cell death in a neuronal cell model. PLoS One 7:e52637.
104. Karbowski M, Jeong SY, Youle RJ (2004) Endophilin Bl is required for the maintenance of mitochondrial morphology. J Cell Biol 166:1027-1039. (Pubitemid 39304766)
105. Yu T, Fox RJ, Burwell LS, Yoon Y (2005) Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFisl. J Cell Sci 118:4141-4151. (Pubitemid 41488953)
106. Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C (2005) Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 280:35742-35750. (Pubitemid 41532767)
107. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, et al. (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1:515-525. (Pubitemid 33586103)
108. Wasiak S, Zunino R, McBride HM (2007) Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177:439-450. (Pubitemid 46718273)
109. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, et al. (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. Embo J 25:3900-3911. (Pubitemid 44300275)
110. Germain M, Mathai JP, McBride HM, Shore GC (2005) Endoplasmic reticulum BIK initiates DRPl-regulated remodelling of mitochondrial cristae during apoptosis. Embo J 24:1546-1556. (Pubitemid 40646445)
111. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fisl, Drpl, and Opal in apoptosis. Mol Biol Cell 15:5001-5011. (Pubitemid 39392214)
112. Thomas KJ, Jacobson MR (2012) Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model. PLoS One 7:e45319.
113. Parone PA, Da Cruz S, Tondera D, Mattenberger Y, James DI, et al. (2008) Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One 3:e3257.
114. Qian W, Choi S, Gibson GA, Watkins SC, Bakkenist CJ, et al. (2012) Mitochondrial hyperfusion induced by loss of the fission protein Drpl causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress. J Cell Sci 125:5745-5757.
115. Suen DF, Norris KL, Youle RJ (2008) Mitochondrial dynamics and apoptosis. Genes Dev 22:1577-1590. (Pubitemid 351846838)
116. Horn SR, Thomenius MJ, Johnson ES, Freel CD, Wu JQ, et al. (2011) Regulation of mitochondrial morphology by APC/CCdhlmediated control of Drpl stability. Mol Biol Cell 22:1207-1216.
117. Bossy B, Petrilli A, Klinglmayr E, Chen J, Lutz-Meindl U, et al. (2010) S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis 20 Suppl2:S513-526.
118. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K (2007) Mitotic phosphorylation of dynamin-related GTPase Drpl participates in mitochondrial fission. J Biol Chem 282:11521-11529. (Pubitemid 47100787)
119. Chang CR, Blackstone C (2007) Cyclic AMP-dependent protein kinase phosphorylation of Drpl regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282:21583-21587. (Pubitemid 47195725)
120. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, et al. (2000) Overexpression of cyclin Bl in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60:4000-4004. (Pubitemid 30636572)
121. Matthess Y, Raab M, Sanhaji M, Lavrik IN, Strebhardt K (2010) Cdkl/cyclin Bl controls Fas-mediated apoptosis by regulating caspase-8 activity. Mol Cell Biol 30:5726-5740.
122. Feldmann G, Mishra A, Hong SM, Bisht S, Strock CJ, et al. (2010) Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res 70:4460-4469.
123. Wang K, Long B, Jiao JQ, Wang JX, Liu JP, et al. (2012) miR-484 regulates mitochondrial network through targeting Fisl. Nat Commun 3:781.
124. Wang X, Herr RA, Hansen T (2008) Viral and cellular MARCH ubiquitin ligases and cancer. Semin Cancer Biol 18:441-450.
125. Karbowski M, Neutzner A, Youle RJ (2007) The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drpl dependent mitochondrial division. J Cell Biol 178:71-84. (Pubitemid 47026403)
126. Cuddeback SM, Yamaguchi H, Komatsu K, Miyashita T, Yamada M, et al. (2001) Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 276:20559-20565.
127. Farsad K, Ringstad N, Takei K, Floyd SR, Rose K, et al. (2001) Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J Cell Biol 155:193-200. (Pubitemid 34289294)
128. Pierrat B, Simonen M, Cueto M, Mestan J, Ferrigno P, et al. (2001) SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics 71:222-234. (Pubitemid 32165089)
129. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, et al. (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 9:1142-1151. (Pubitemid 47500490)
130. Takahashi Y, Karbowski M, Yamaguchi H, Kazi A, Wu J, et al. (2005) Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol 25:9369-9382. (Pubitemid 41507838)
131. Sugioka R, Shimizu S, Tsujimoto Y (2004) Fzol, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem 279:52726-52734. (Pubitemid 39656648)
132. Liesa M, Palacin M, Zorzano A (2009) Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89:799-845.
133. Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, et al. (2001) Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display. Cancer Res 61:8873-8879.
134. Chen KH, Guo X, Ma D, Guo Y, Li Q, et al. (2004) Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6:872-883. (Pubitemid 39207252)
135. Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Lower B, et al. (2008) Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 22:476-488. (Pubitemid 351272755)
136. Olichon A, Baricault L, Gas N, Guillou E, Valette A, et al. (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278:7743-7746. (Pubitemid 36800505)
137. Fang HY, Chen CY, Chiou SH, Wang YT, Lin TY, et al. (2012) Overexpression of optic atrophy 1 protein increases cisplatin resistance via inactivation of caspase-dependent apoptosis in lung adenocarcinoma cells. Hum Pathol 43:105-114.
138. Neuspiel M, Zunino R, Gangaraju S, Rippstein P, McBride H (2005) Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem 280:25060-25070. (Pubitemid 40934597)
139. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, et al. (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126:177-189.
140. Chipuk JE, Bouchier-Hayes L, Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13:1396-1402. (Pubitemid 44057475)
141. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, et al. (2002) Spatial and temporal association of Bax with mitochondrial fission sites, Drpl, and Mfn2 during apoptosis. J Cell Biol 159:931-938. (Pubitemid 36055748)
142. Youle RJ, Karbowski M (2005) Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 6:657-663. (Pubitemid 41081269)
143. McMahon HT, Gallop JL (2005) Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438:590-596. (Pubitemid 41740562)
144. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, et al. (2002) A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2:55-67. (Pubitemid 34065906)
145. Bernardi P, Azzone GF (1981) Cytochrome c as an electron shuttle between the outer and inner mitochondrial membranes. J Biol Chem 256:7187-7192.
146. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S (2002) Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A 99:1259-1263. (Pubitemid 34136480)
147. 2+-mediated apoptosis. Mol Cell 16:59-68. (Pubitemid 39330152)